Literature DB >> 27403239

Prevalence of Metabolic Syndrome in Patients with Schizophrenia Referred to Farabi Hospital, Kermanshah, Iran.

Jalal Shakeri1, Kamyar Karimi1, Vahid Farnia1, Senobar Golshani1, Mostafa Alikhani1.   

Abstract

OBJECTIVES: Our study was conducted to determine the prevalence of metabolic syndrome in patients with schizophrenia.
METHODS: The study population included all patients with schizophrenia who were referred to Farabi Hospital, Kermanshah, Iran, between March 2014 and March 2015. A total of 280 subjects who met the study criteria were selected according to the census sampling method.
RESULTS: The prevalence of metabolic syndrome was 30.4% (20.7% in men and 51.5% in women). The prevalence of metabolic syndrome was greater in patients > 40 years than patients aged 20-40 years. There was a significant relationship between marital status and number of hospitalizations with the prevalence of metabolic syndrome.
CONCLUSIONS: Given the high prevalence of metabolic syndrome in patients with schizophrenia, healthcare professionals should take measures to identify the risk factors and timely treatment of affected patients, thereby improving the patient's quality of life and reducing health costs.

Entities:  

Keywords:  Metabolic Syndrome; Patients; Schizophrenia

Year:  2016        PMID: 27403239      PMCID: PMC4927727          DOI: 10.5001/omj.2016.53

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  27 in total

1.  Acute effects of newer antipsychotic drugs on glucose metabolism.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

2.  The metabolic syndrome and inflammation: 
role of insulin resistance and increased adiposity.

Authors:  Wajiha Farooq; Umme Farwa; Faisal Rashid Khan
Journal:  Oman Med J       Date:  2015-03

3.  Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Authors:  David C Henderson; Enrico Cagliero; Paul M Copeland; Christina P Borba; Anne Eden Evins; Doug Hayden; Mary T Weber; Ellen J Anderson; David B Allison; Tara B Daley; David Schoenfeld; Donald C Goff
Journal:  Arch Gen Psychiatry       Date:  2005-01

4.  Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome.

Authors:  Zeina A Al-Thanoon; Isam H Mahmood
Journal:  Oman Med J       Date:  2012-01

5.  The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.

Authors:  Paulo José Ribeiro Teixeira; Fábio Lopes Rocha
Journal:  Braz J Psychiatry       Date:  2007-12       Impact factor: 2.697

6.  Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea.

Authors:  Myoung-Hee Kim; Mi-Kyung Kim; Bo-Youl Choi; Young-Jeon Shin
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

7.  Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Sarah D de Ferranti; Kimberlee Gauvreau; David S Ludwig; Ellis J Neufeld; Jane W Newburger; Nader Rifai
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

8.  Metabolic syndrome in patients with schizophrenia.

Authors:  Tuula Heiskanen; Leo Niskanen; Riitta Lyytikäinen; Pirjo I Saarinen; Jukka Hintikka
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

9.  The prevalence of the metabolic syndrome among arab americans.

Authors:  Linda A Jaber; Morton B Brown; Adnan Hammad; Qian Zhu; William H Herman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

Authors:  Alireza Delavari; Mohammad Hossein Forouzanfar; Siamak Alikhani; Afsaneh Sharifian; Roya Kelishadi
Journal:  Diabetes Care       Date:  2009-03-11       Impact factor: 19.112

View more
  3 in total

1.  Sleep Paralysis, a Medical Condition with a Diverse Cultural Interpretation.

Authors:  Esther Olunu; Ruth Kimo; Esther Olufunmbi Onigbinde; Mary-Amadeus Uduak Akpanobong; Inyene Ezekiel Enang; Mariam Osanakpo; Ifure Tom Monday; David Adeiza Otohinoyi; Adegbenro Omotuyi John Fakoya
Journal:  Int J Appl Basic Med Res       Date:  2018 Jul-Sep

2.  Metabolic Syndrome among Schizophrenic Patients: A Comparative Cross-Sectional Study in the Middle Belt of Ghana.

Authors:  Angela Owusu-Ansah; Anto Berko Panyin; Christian Obirikorang; Christian Agyare; Emmanuel Acheampong; Simon Kwofie; Enoch Odame Anto; Emmanuella Nsenbah Batu
Journal:  Schizophr Res Treatment       Date:  2018-06-28

3.  Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics.

Authors:  Shadi Naderyan Fe'li; Seyed Mojtaba Yassini Ardekani; Hosein Fallahzadeh; Ali Dehghani
Journal:  Med J Islam Repub Iran       Date:  2019-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.